Summary of Purpose
Ischemic stroke, which is due to the occlusion of a cerebral blood vessel, comprises nearly 90% of all strokes. Currently, reperfusion of the salvageable tissue via thrombolytic drug or endovascular treatment is the most effective strategy to reduce brain damage. However, after recanalizing the occluded vessels, subsequent reperfusion injury is inevitable. It may not only weaken the therapeutic effects of timely...Read More →
The following dates are available for this trial. Trial information last updated on 18 March 2018.
|20 Mar 2018||3 Feb 2017||1 Jun 2019||1 Sep 2019||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|